Endocrine aspects of pre-eclampsia

Gemma Currie, David M. Carty, John M. Connell, Marie Freel

    Research output: Contribution to journalArticle

    Abstract

    Pre-eclampsia, defined as hypertension with proteinuria occurring after 20 weeks' gestation, complicates up to 8% of pregnancies and is a major contributor to perinatal morbidity and mortality worldwide. It is now widely accepted that pre-eclampsia is also associated with the risk of maternal cardiovascular disease in later life. Although the pathogenesis of this complex condition remains incompletely understood, impaired placentation and subsequent endothelial dysfunction and inflammation are among the proposed hypotheses. In recent years, there has been a resurgence of interest in the pivotal role of aldosterone and volume status in pre-eclamptic pregnancy. This review will focus on the endocrine mechanisms believed to underpin development of pre-eclampsia and its early and late complications.

    Original languageEnglish
    Pages (from-to)1-10
    Number of pages10
    JournalCardiovascular Endocrinology
    Volume4
    Issue number1
    DOIs
    Publication statusPublished - Mar 2015

    Fingerprint

    Pre-Eclampsia
    Pregnancy
    Placentation
    Perinatal Mortality
    Aldosterone
    Proteinuria
    Cardiovascular Diseases
    Mothers
    Hypertension
    Inflammation
    Morbidity

    Keywords

    • aldosterone
    • angiogenesis
    • angiotensin
    • cortisol
    • insulin
    • placenta
    • pre-eclampsia
    • pregnancy
    • renin
    • trophoblast

    Cite this

    Currie, G., Carty, D. M., Connell, J. M., & Freel, M. (2015). Endocrine aspects of pre-eclampsia. Cardiovascular Endocrinology, 4(1), 1-10. https://doi.org/10.1097/XCE.0000000000000039
    Currie, Gemma ; Carty, David M. ; Connell, John M. ; Freel, Marie. / Endocrine aspects of pre-eclampsia. In: Cardiovascular Endocrinology. 2015 ; Vol. 4, No. 1. pp. 1-10.
    @article{2150198632784948a052cee3c7e7d6f2,
    title = "Endocrine aspects of pre-eclampsia",
    abstract = "Pre-eclampsia, defined as hypertension with proteinuria occurring after 20 weeks' gestation, complicates up to 8{\%} of pregnancies and is a major contributor to perinatal morbidity and mortality worldwide. It is now widely accepted that pre-eclampsia is also associated with the risk of maternal cardiovascular disease in later life. Although the pathogenesis of this complex condition remains incompletely understood, impaired placentation and subsequent endothelial dysfunction and inflammation are among the proposed hypotheses. In recent years, there has been a resurgence of interest in the pivotal role of aldosterone and volume status in pre-eclamptic pregnancy. This review will focus on the endocrine mechanisms believed to underpin development of pre-eclampsia and its early and late complications.",
    keywords = "aldosterone, angiogenesis, angiotensin, cortisol, insulin, placenta, pre-eclampsia, pregnancy, renin, trophoblast",
    author = "Gemma Currie and Carty, {David M.} and Connell, {John M.} and Marie Freel",
    year = "2015",
    month = "3",
    doi = "10.1097/XCE.0000000000000039",
    language = "English",
    volume = "4",
    pages = "1--10",
    journal = "Cardiovascular Endocrinology",
    issn = "2162-6898",
    publisher = "Lippincott, Williams & Wilkins",
    number = "1",

    }

    Currie, G, Carty, DM, Connell, JM & Freel, M 2015, 'Endocrine aspects of pre-eclampsia', Cardiovascular Endocrinology, vol. 4, no. 1, pp. 1-10. https://doi.org/10.1097/XCE.0000000000000039

    Endocrine aspects of pre-eclampsia. / Currie, Gemma; Carty, David M.; Connell, John M.; Freel, Marie.

    In: Cardiovascular Endocrinology, Vol. 4, No. 1, 03.2015, p. 1-10.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Endocrine aspects of pre-eclampsia

    AU - Currie, Gemma

    AU - Carty, David M.

    AU - Connell, John M.

    AU - Freel, Marie

    PY - 2015/3

    Y1 - 2015/3

    N2 - Pre-eclampsia, defined as hypertension with proteinuria occurring after 20 weeks' gestation, complicates up to 8% of pregnancies and is a major contributor to perinatal morbidity and mortality worldwide. It is now widely accepted that pre-eclampsia is also associated with the risk of maternal cardiovascular disease in later life. Although the pathogenesis of this complex condition remains incompletely understood, impaired placentation and subsequent endothelial dysfunction and inflammation are among the proposed hypotheses. In recent years, there has been a resurgence of interest in the pivotal role of aldosterone and volume status in pre-eclamptic pregnancy. This review will focus on the endocrine mechanisms believed to underpin development of pre-eclampsia and its early and late complications.

    AB - Pre-eclampsia, defined as hypertension with proteinuria occurring after 20 weeks' gestation, complicates up to 8% of pregnancies and is a major contributor to perinatal morbidity and mortality worldwide. It is now widely accepted that pre-eclampsia is also associated with the risk of maternal cardiovascular disease in later life. Although the pathogenesis of this complex condition remains incompletely understood, impaired placentation and subsequent endothelial dysfunction and inflammation are among the proposed hypotheses. In recent years, there has been a resurgence of interest in the pivotal role of aldosterone and volume status in pre-eclamptic pregnancy. This review will focus on the endocrine mechanisms believed to underpin development of pre-eclampsia and its early and late complications.

    KW - aldosterone

    KW - angiogenesis

    KW - angiotensin

    KW - cortisol

    KW - insulin

    KW - placenta

    KW - pre-eclampsia

    KW - pregnancy

    KW - renin

    KW - trophoblast

    UR - http://www.scopus.com/inward/record.url?scp=84954359831&partnerID=8YFLogxK

    U2 - 10.1097/XCE.0000000000000039

    DO - 10.1097/XCE.0000000000000039

    M3 - Article

    VL - 4

    SP - 1

    EP - 10

    JO - Cardiovascular Endocrinology

    JF - Cardiovascular Endocrinology

    SN - 2162-6898

    IS - 1

    ER -